3D-Printed Patient-Specific Surgical Plates Versus Conventional Surgical Plates in Jaw Reconstruction
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04635865 |
Recruitment Status :
Recruiting
First Posted : November 19, 2020
Last Update Posted : April 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Objectives: The aim of this randomised controlled clinical trial is to evaluate surgical accuracy and efficiency of computer-assisted jaw reconstruction using 3D-printed patient-specific titanium surgical plates versus conventional plates.
Hypothesis to be tested: The investigators hypothesize that compared to conventional surgical plates, 3D-printed patient-specific surgical plates improve surgical accuracy and efficiency of computer assisted jaw reconstruction.
Design and subjects: This is an open-label, prospective, double-arm, and single-centre randomised controlled clinical trial. Patients with maxillary or mandibular neoplastic, inflammatory and congenital diseases who require immediate or secondary reconstructive surgery will be invited to participate in the study.
Study instruments: 3D-printed patient-specific titanium surgical plates and conventional plates.
Main Outcome Measures: The primary endpoint is the accuracy of reconstruction. The secondary endpoints include the accuracy of osteotomy, reconstruction time, total operative time, intraoperative blood loss, length of post-operative hospital stay, and postoperative adverse events.
Data analysis: The accuracy parameters, reconstruction time, total operative time, intraoperative blood loss, length of post-operative hospital stay will be presented as mean values with standard deviations. The post-operative adverse events will be calculated and presented as frequency with standard deviation.
Expected results: This randomised control trial will prove improved accuracy and efficiency of reconstruction using 3D printed patient-specific titanium surgical plates. This study is expected to provide high-level evidence to push forward the popularity of using 3D medical printing technology in surgical field.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mandibular Neoplasms Maxillary Neoplasms Dentofacial Deformities | Device: 3D-printed patient-specific plate Device: Conventional commercial reconstruction plate | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 92 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Patients fulfilling the eligibility criteria and willing to participate will be randomised after baseline assessment (1:1 allocation ratio). A priori, an independent statistician will prepare a computer-generated randomisation schedule in a random-sized permuted blocks of four or six patients stratified by location of reconstruction (maxilla/mandible) and gender (F/M) to ensure that the numbers of participants receiving the two interventions are closely balanced within each stratum. The allocation numbers will be concealed in opaque sealed envelopes prepared by a central study coordinator, only opening them after informed consent and baseline measures have been obtained. |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Computer-Assisted Jaw Reconstruction Using 3D-Printed Patient-Specific Surgical Plates Versus Conventional Surgical Plates: A Randomised Controlled Clinical Trial |
Actual Study Start Date : | December 1, 2020 |
Estimated Primary Completion Date : | November 30, 2025 |
Estimated Study Completion Date : | February 28, 2026 |

Arm | Intervention/treatment |
---|---|
Experimental: 3D-printed patient-specific plate group
3D-printed patient-specific plate will be used for reconstruction in this patient group
|
Device: 3D-printed patient-specific plate
We adopt an in-house approach for designing by surgeons. All patient-specific devices are designed in 3-matic 13.0 (Materialise). Both cutting and transferring guides are then additively manufactured by Fused Deposition Manufacturing (FDM) using ULTEM 1010, or by Stereolithography using MED610 resin (Stratasys Ltd, Eden Prairie, MN, USA). Both ULTEM 1010 and MED610 are FDA cleared biocompatible materials applicable to high-temperature autoclaving. Patient-specific surgical plates are designed by delineating a plate path on bone surface, then followed by the placement of screw holes. Surgical plates are generated by the built-in command in 3-matic. After that, surgical plates are fabricated by SLM using grade 2 titanium powder. |
Active Comparator: Conventional plate group
conventional commercial plates will be used for reconstruction in this patient group
|
Device: Conventional commercial reconstruction plate
Bone segments will be stabilized using commercial titanium surgical plates (DePuy Synthes, United States), which are bent manually before fastening the screws.[ |
- Accuracy of reconstruction [ Time Frame: through study completion, an average of 5 years ]The primary endpoint is accuracy of reconstruction, which is defined as the distance or angulation deviations of anatomical landmarks between the virtual plan and actual surgical outcome.
- accuracy of osteotomy [ Time Frame: after surgery for each case, through study completion, an average of 5 years ]Deviation of actual osteotomy from the digital planning
- reconstruction time [ Time Frame: during surgery for each case, through study completion, an average of 5 years ]time from the start of flap ischemia to the finish of anastomosis and internal fixation
- total operative time [ Time Frame: during surgery for each case, through study completion, an average of 5 years ]total operative time
- intraoperative blood loss [ Time Frame: during surgery for each case, through study completion, an average of 5 years ]intraoperative blood loss
- length of post-operative hospital stay [ Time Frame: after surgery for each case, through study completion, an average of 5 years ]length of post-operative hospital stay
- postoperative adverse events [ Time Frame: after surgery for each case, through study completion, an average of 5 years ]postoperative adverse events

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age greater than 18 years, of both gender;
- Provision of signed and dated informed consent form;
- Diagnosed with maxillofacial benign or malignant tumours or inflammatory or congenital diseases and indicated for computer-assisted jaw surgery;
- Primary or secondary reconstruction with autogenous bony free flaps or graft will be needed;
- Titanium plates will be used for internal fixation for the reconstruction surgery;
- Agree to comply with follow-up procedures.
Exclusion Criteria:
- Patients who are pregnant;
- Patients who have medically compromised conditions and cannot tolerate the surgery;
- Systemic conditions or diseases that violate the normal bone healing;
- Patients who are unable to take the preoperative and postoperative CT/CBCT scans;
- Patients who are unable to have a two-week period prior to surgery, for virtual surgery simulation, 3D patient-specific surgical plate design and fabrication.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04635865
Contact: Yuxiong Su, Dr. | 852 2859 0267 | richsu@hku.hk |
Hong Kong | |
The Prince Philip Dental Hospital | Recruiting |
Hong Kong, Hong Kong, 000000 | |
Contact: Yuxiong Su, Dr. 852 2859 0267 richsu@hku.hk |
Principal Investigator: | Yuxiong Su, Dr. | The University of Hong Kong |
Responsible Party: | Dr. Yuxiong Su, Clinical Associate Professor, The University of Hong Kong |
ClinicalTrials.gov Identifier: | NCT04635865 |
Other Study ID Numbers: |
UW 20-548 |
First Posted: | November 19, 2020 Key Record Dates |
Last Update Posted: | April 8, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
3D printing patient-specific titanium plate mandibular malignancy |
dento-maxillofacial deformity mandibular reconstruction maxillary reconstruction |
Neoplasms Maxillary Neoplasms Mandibular Neoplasms Dentofacial Deformities Congenital Abnormalities Maxillofacial Abnormalities Craniofacial Abnormalities Musculoskeletal Abnormalities Musculoskeletal Diseases Stomatognathic System Abnormalities |
Stomatognathic Diseases Jaw Neoplasms Skull Neoplasms Bone Neoplasms Neoplasms by Site Bone Diseases Jaw Diseases Maxillary Diseases Mandibular Diseases |